🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Micron, CureVac Fall Premarket; Walgreens Rises

Published 07/01/2021, 07:51 AM
Updated 07/01/2021, 07:52 AM
© Reuters.
XLNX
-
MKC
-
MU
-
AMD
-
WBA
-
GSK
-
NIO
-
CVAC
-
XPEV
-
DIDIY
-

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Thursday, July 1st. Please refresh for updates.

  • CureVac (NASDAQ:CVAC) stock fell 13% after the German drugmaker said final test data showed its experimental vaccine against Covid-19 was only 48% effective in preventing the disease, a much lower percentage than the rival drugs.

  • Walgreens Boots (NASDAQ:WBA) stock rose 1.7% after the pharmacy chain raised its 2021 adjusted profit growth forecast, buoyed by strength in drug sales and Covid-19 vaccine administrations.

  • Micron (NASDAQ:MU) stock fell 1.7% after the chipmaker warned that industry-wide supplies of memory chips will remain tight until the end of next year, and it would put out the production of its most cutting-edge chips until 2024.

  • Didi Global (NYSE:DIDI) stock rose 7.4%, a day after the Chinese ride-hailing company made its Wall Street debut, ending just over the IPO price, with a market value of around $68 billion.

  • Xpeng (NYSE:XPEV) stock rose 3.7% after the Chinese electric car manufacturer delivered a seven-fold increase in vehicle sales in June. Fellow Chinese EV maker Nio (NYSE:NIO) ADR rose 3% after reporting a 116% increase in car sales in June from a year ago.

  • GlaxoSmithKline (NYSE:GSK) ADR rose 0.6% after the Wall Street Journal reported that activist investor Elliott is pushing for a shake-up at the British drugs giant, calling for changes in its board and also potentially at the CEO role.

  • Advanced Micro Devices (NASDAQ:AMD) stock rose 0.8% after the semiconductor maker secured unconditional EU antitrust approval for its $35 billion bid for Xilinx (NASDAQ:XLNX), up 0.4%.

  • McCormick (NYSE:MKC) stock rose 0.4% after the food company raised its full-year sales forecast, after beating quarterly earnings and revenue expectations, helped by strong at-home demand and a rebound in the company’s commercial business.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.